Wan Kamarul Zaman Wan Safwani1, Suzana Makpol2, Somasundaram Sathapan3, Kienhui Chua1. 1. Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. 2. Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. 3. Subang Jaya Medical Centre, Selangor, Malaysia.
Abstract
INTRODUCTION: Adipose tissue is a source of multipotent adult stem cells. Most studies on human adipose-derived stem cells (ASC) have been on the early passages. Studies in extensive expansion have not been well established yet. In this study, we aim to investigate the effects of extensive expansion on the adipogenic differentiation capability of ASC. MATERIAL AND METHODS: The ability of ASC to undergo adipogenic differentiation in extensive expansion was evaluated by morphological changes, differentiation assay by using Oil Red O staining and changes in the genes expression levels of adipogenic genes, osteogenic genes and stemness genes using quantitative polymerase chain reaction (qPCR) after induction. RESULTS: Morphological study showed that the formation of lipid droplets can be observed at all passages but decreased at P20 after induction. Data from qPCR showed that most adipogenicgenes expression increased significantlyat P5, P10 and P15 but decreased at P20 after induction. On the other hand, osteogenic genes showed no significant changes after adipogenic induction indicating low potentiality of adipogenic-induced ASC to become osteogenic cells. While stemness genes expression levels showed a decrease or no significant changes after adipogenic induction except Nanog3, which showed a significant increase at P15 and P20. CONCLUSIONS: The ability of ASC to differentiate into mature adipogenic cells decreased after P10 and the decrease in the osteogenics gene expression level during adipogenic induction suggested that the osteogenesis and adipogenesis are not parallel events.
INTRODUCTION: Adipose tissue is a source of multipotent adult stem cells. Most studies on human adipose-derived stem cells (ASC) have been on the early passages. Studies in extensive expansion have not been well established yet. In this study, we aim to investigate the effects of extensive expansion on the adipogenic differentiation capability of ASC. MATERIAL AND METHODS: The ability of ASC to undergo adipogenic differentiation in extensive expansion was evaluated by morphological changes, differentiation assay by using Oil Red O staining and changes in the genes expression levels of adipogenic genes, osteogenic genes and stemness genes using quantitative polymerase chain reaction (qPCR) after induction. RESULTS: Morphological study showed that the formation of lipid droplets can be observed at all passages but decreased at P20 after induction. Data from qPCR showed that most adipogenicgenes expression increased significantlyat P5, P10 and P15 but decreased at P20 after induction. On the other hand, osteogenic genes showed no significant changes after adipogenic induction indicating low potentiality of adipogenic-induced ASC to become osteogenic cells. While stemness genes expression levels showed a decrease or no significant changes after adipogenic induction except Nanog3, which showed a significant increase at P15 and P20. CONCLUSIONS: The ability of ASC to differentiate into mature adipogenic cells decreased after P10 and the decrease in the osteogenics gene expression level during adipogenic induction suggested that the osteogenesis and adipogenesis are not parallel events.
Adipose tissue is a source of multipotent adult stem cells and it has been used in tissue engineering as well as in regenerative medicine. The advantages of using adipose tissue as a stem cell source are that it can be obtained in abundance, it has been found to have multilineage differentiation potential and it can be harvested easily with a minimally invasive method compared to bone marrow. Adipose-derived stem cells (ASC) can differentiate into chondrogenic cells, adipogenic cells, osteogenic cells [1] and neurogenic cells [2]. However, one study reported that bone marrow stem cells (BMSC) have a superior potential for osteogenesis compared to ASC [3]. One of the ideal characteristics of stem cells is that they should be able to maintain their multilineage differentiation ability while they are in long-term culture or undergo extensive subculture. Guilak et al. reported that adipose-derived human mesenchymal stem cells can undergo clonal expansion while maintaining their differentiation ability [4]. However, most of the research on ASC differentiation has been carried out at the early passages (P1–P5) [5, 6].Adipogenesis is a process which occurs when stem cells differentiate into adipocytes and it happen throughout an organism's lifetime. The function of adipocytes is to store triglycerides during energy excess and mobilise them during deprivation, which is controlled by the lipogenic and lipolytic processes through hormonal signals from the bloodstream [7]. The process of adipogenesis starts with pluripotent mesoderm stem cells. During adipogenic differentiation, committed preadipocytes will withdraw from the cell cycle before undergoing adipose conversion as growth arrest is required for this differentiation [8]. After that, appropriate combination of mitogenic and adipogenic signals is needed to proceed to the next step of the differentiation, which lead to the changes in morphological and biochemical characteristics of the mature adipocyte [9]. There are several genes involved in the adipogenic differentiation. Peroxisome proliferator-activated receptor-γ (PPAR) is the main gene in adipogenic differentiation and it maintains adipocyte specific functions such as lipid storage [10]. Lipoprotein lipase (LPL) is involved in lipid metabolism and transport by catalyzing the rate-limiting step in the hydrolysis of the triacylglycerol component [11]. The activation of LPL gene transcription was found to be induced by the PPAR gene in macrophages [12]. Fatty acid binding protein (aP2) plays an important role in the development of metabolic syndrome and the coordination of cholesterol trafficking as well as inflammatory activity [13, 14]. These genes can be used as markers to study the progression of stem cells in adipogenic differentiation, especially in long-term culture. The quantitative evaluation of these genes is important to determine the threshold level at which the stem cells can differentiate efficiently.Apart from these genes, stemness genes, e.g. Nanog3 and Sox2, should be studied as well during the progression of stem cell differentiation into other lineages. How these stemness genes affect the process of differentiation, whether their expressions are up-regulated or not, is yet to be established. Our previous study on the effect of long-term culture on ASC showed that the stemness gene expression level decreased from P5 to P15, which indicated that the ability of the cells to differentiate after serial passaging may have decreased as well [15]. Genes involved in osteogenic differentiation, e.g. osteopontin (OSP) and alkaline phosphatase (ALP), should also be studied as osteogenesis shares a similar pathway as adipogenesis. There is a possibility for osteogenic genes to be up-regulated during adipogenic differentiation, as reported by Wall et al. [16]. One study showed that bone marrow-derived stem cells were able to maintain their osteogenic differentiation ability through 10–15 passages but not their adipogenic ability, which declined after serial passaging [17]. However, another study reported the adipogenic differentiation ability of bone marrow-derived stem cells was variable after clonal expansion [18]. In addition, it is still unclear whether ASC are able to maintain their differentiation ability in long-term culture.Although adipose tissue is regarded as a waste by many people, studies have shown that it has many clinical applications, especially in cosmetic surgery. One of the most common is breast augmentation using lipo-injection technique, combining autologous adipose derived stem (stromal) cells (ASC) with fat [19]. Another common procedure is the intradermal injection of ASC in the treatment of skin aging, especially for wrinkles [20]. In order to be used clinically, millions of stem cells need to be harvested and injected or implanted into the patients. Therefore, they need to be expanded for an extended period of time to obtain a huge number of cells for clinical application. However, the effect of long-term culture on the ability of ASC to differentiate into adipogenic cells as well as their molecular activity is still relatively unknown. Furthermore, it is important to determine at which passage expression of these genes starts to alter. These data may be used as an indicator in ASC long-term differentiation. In this study, we analysed the expression levels of the adipogenic genes, osteogenic genes and stemness genes before and after adipogenic induction of ASC in extensive culture using quantitative PCR (qPCR). The expression levels of these genes can reveal the molecular behaviour of ASC in the progression of adipogenic differentiation. The data can then be used to evaluate the efficiency of ASC to undergo adipogenic differentiation in long-term culture.
Material and methods
Isolation and culture of human adipose-derived stem cells
The ASC were harvested from human lipoaspirate tissue, which was obtained from 6 patients (age: 40–60 years old) undergoing intraoperative suction lipectomy at the Subang Jaya Medical Centre, Malaysia. The use of human tissue and cells for research purposes in this study was approved by Universiti Kebangsaan Malaysia Research and Ethical Committee (Project code: 02-01-02-SF0290). The lipoaspirate tissue was digested using 0.3% Collagenase Type I (Sigma-Aldrich, St Louise, MO) for 2 h at 37°C. The digested tissue was centrifuged at 1200 γ for 10 min. The supernatant was discarded and the cell pellet was washed using phosphate buffered saline (PBS) twice. The cells were cultured in Dulbecco's Modified Eagle Medium (DMEM)/Ham F12 medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) (Fisher Scientific, USA), 1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA), 1% Glutamax (Invitrogen) and 1% vitamin C (Sigma-Aldrich). Cell cultures were incubated and maintained at 37°C with 5% carbon dioxide. They were fed every 3 days. The cells were grown to confluence after the initial plating (P = 0) and they were sub-cultured at 1: 4 expansion under the same condition for an extensive culture period until passage 20. Once confluent (80–90%), the adherent cells were detached using 0.125% trypsin-EDTA (Invitrogen) and they were either re-plated at 2000 to 2500 cells/cm2 or used for experimental analysis. Cell viability and numbers at the time of passage were determined by trypan blue exclusion and haemocytometer cell counts. Cells cultured at passages 5, 10, 15 and 20 were used for analysis. Phase contrast images of cell morphology were captured at P5, P10, P15 and P20.
In vitro adipose-derived stem cells adipogenic differentiation and morphological evaluation
The adipogenic differentiation capability of cultured ASC at various passages (P5, P10, P15 and P20) was tested by using the adipogenic differentiation medium (Dulbecco's Modified Eagle Medium (DMEM)/Ham F12) (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (Invitrogen), 1% (v/v) antibiotic antimycotic (Invitrogen), 1% (v/v) Glutamax (Invitrogen), 1% (v/v) vitamin C (Sigma-Aldrich), 200 µM indomethacin (Sigma-Aldrich), 10 µM insulin (Sigma-Aldrich), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich) and 1 µM dexamethasone (Sigma-Aldrich). Cells were seeded at 2500 cells/cm2 in a 28 mm2 cell culture plate and maintained in a 5% CO2 incubator (RS Biotech Galaxy Plus, Scotland, UK) at 37°C under 95% humidity for 3 weeks. The cell cultures were maintained in normal cell culture medium for 3 days before changing to the adipogenic differentiation medium. The two media were alternately changed every 3 days due to the toxicity of the adipogenic differentiation medium. The ASC underwent adipogenic induction for 3 weeks. Cultures were examined every day by using an inverted phase contrast microscope for monitoring cells’ morphological changes. Photographs were taken to record the changes in cell morphology.Adipogenic cells were identified by the formation of lipid droplets in the cell cytoplasm. The lipid droplets were stained red with Oil Red O staining (Sigma-Aldrich). After adipogenic induction, the cells were fixed with 10% (v/v) formalin. The seeded cells were rinsed with distilled water thrice and they were dipped into 60% aqua triethyl phosphate solution. The cells were then stained with oil red O for 15 min and rinsed with distilled water. The cells were then stained with Gill's haematoxylin and mounted with buffered glycerine. The stained cells were observed under the inverted contrast phase microscope (Olympus, Shinjuku-ku, Tokyo) for evaluation. The percentage of differentiated ASCs that produced lipid droplets was quantified using an image analyzer (Leica Microsystems, Wetzlar, Germany).
Total RNA extraction
Total RNA was extracted from the non-differentiated and differentiated ASCs cultured at P5, P10, P15 and P20. The RNA was homogenised and extracted using TRI reagent (Molecular Research Center, Cincinnati, OH). Chloroform was used for phase separation of the sample. Total RNA from the sample was precipitated by using isopropanol and polyacryl carrier (Molecular Research Center). The RNA extract was then centrifuged at 12 000 γ for 8 min at 4°C. Seventy-five percent ethanol was used to wash the extract. RNase and DNase free distilled water (Invitrogen) was used to solubilise the RNA extract.
cDNA synthesis
The solubilised RNA extracts from ASCs cultured at P5, P10, P15 and P20 were used to synthesise cDNA by using SuperScript III First-Strand Synthesis SuperMix kit for two-step quantitative RT-PCR (Invitrogen). The synthesis was carried out according to the optimised protocol recommended by the manufacturer. The protocol conditions were 10 min at 23°C, 60 min at 42°C and 10 min at 94°C. The synthesised cDNA was used to perform quantitative polymerase chain reaction (qPCR) to determine the expression level of the stemness genes, adipogenic genes and osteogenic genes.
Quantitative polymerase chain reaction
The non-differentiated and differentiated ASCs cultured at P5, P10, P15 and P20 were analysed for expression level of stemness genes, .e. Sox-2, Nanog3, Nestin, BST-1 (bone marrow stromal antigen 1) and Oct-4. Expression of adipogenic genes LPL, aP2 and PPAR-γ as well as osteogenic genes BSP (bone sialoprotein), RUNX, ALP (alkaline phosphatase), OSP (osteopontin) and OSC (osteocalcin) was also evaluated. Primers for each gene were designed by using Primer 3 software based on the published GenBank database sequences. The PCR reaction was carried out using SYBR Green as the indicator in a Bio-Rad iCycler PCR machine. The reaction mixture consisted of iQ SYBR Supermix, forward and reverse primers (500 nM each), deionised water and 5 µl of cDNA. The reaction conditions were cycle 1: step 1 95°C for 3 min (1 time), cycle 2: step 1 95°C for 10 s and step 2 61°C for 30 s (40 times) and cycle 3 for melting curve analysis. The expression level of each targeted gene was normalised to GAPDH as the housekeeping gene.
Statistical analysis
Data were analysed using SPSS 15.0 (SPSS Inc., Chicago, IL) and subjected to one-way analysis of variance with a Tukey post hoc test to determine significant differences (p < 0.05) in gene expression levels between passages P5, P10, P15 and P20. Data are presented as the mean ± standard error of mean (SEM).
Results
Morphological and growth kinetic changes of adipose-derived stem cells in extensive culture
Extensive sub-cultivation altered the morphology and the growth kinetics of human ASC. The ASC has a fibroblast-like morphology and this feature was most obvious at early passages (P5) (Figure 1A). The cell morphology, i.e. the size and shape, were consistent with minimal alterations at passages P5 to P10 (Figure 1B). However, marked alterations in the cell morphology were observed at passages P15 to P20 (Figures 1C and 1D). This altered morphology was indicated by the disappearance of the fibroblast-like feature and the appearance of large cells with expanded cytoplasmic volume. Passages beyond P20 could not be analysed as the cell growth became so protracted where the cells failed to reach 80–90% confluence even after 3 weeks in culture. The study on ASC growth rate showed no significant changes in the growth rate at P5 (1347 cells/cm2/day), P10 (2413 cells/cm2/day) and P15 (1645 cells/cm2/day) (Figure 2). However, the decline in growth rate was significant (p < 0.05) at P20 (254 cells/cm2/day) (Figure 2) compared to P10.
Figure 1
Representative cell morphology of ASC in extensive culture. A – Passage 5, B – Passage 10, C – Passage 15 and D – Passage 20. Magnification 200×
Figure 2
Growth rate (cell/cm2/day) of ASC in extensive culture from P5 to P20. The growth rate peaked at P10 but decreased significantly at P20
*p < 0.05 relative to P10 by ANOVA post hoc Tukey test
Representative cell morphology of ASC in extensive culture. A – Passage 5, B – Passage 10, C – Passage 15 and D – Passage 20. Magnification 200×Growth rate (cell/cm2/day) of ASC in extensive culture from P5 to P20. The growth rate peaked at P10 but decreased significantly at P20*p < 0.05 relative to P10 by ANOVA post hoc Tukey test
Morphological changes of adipose-derived stem cells undergoing adipogenesis
After 3 days in adipogenic medium, the shape of the cells changed from fibroblastic to a more spherical shape with ‘ghost-like’ features (Figure 3A), which marked the start of adipogenesis. The hallmark of adipogenesis is the formation of lipid droplets where the appearance of lipid droplets can be observed in the cytoplasm of the cells from 7 days onwards after adipogenic induction. The formation of these lipid droplets was more prominent at an early passage (P5) with large and shiny droplets (Figures 3B and 3C) and less prominent at a later passage (P20) with more ghost-like features, which only pick up a small amount of the red stain after Oil Red O staining (Figures 3D and 3E). At P5, the percentage of differentiated ASC that produced lipid droplets was 22.5%. At P10 and P15 the percentage of differentiated ASC was 20% and 10%, respectively, while at P20, the percentage of differentiated ASC that produced lipid droplets was 6%. After 21 days, most cells at P20 died as the cells at this passage cannot withstand the toxicity of adipogenic medium. Differentiated ASCs at P10 and P15 have similar features as P5.
Figure 3
Morphology of adipogenic differentiation of ASC. A – The cells had a more ‘ghost-like’ feature which marked the beginning of adipogenesis. Morphology of ASC after 21 days’ adipogenic induction at P5 (B) and P20 (D). Oil Red O staining of differentiated ASC at P5 (C) and P20 (E). Differentiated ASC at P10 and P15 have similar features as ASC at P5. Magnification 200×
Morphology of adipogenic differentiation of ASC. A – The cells had a more ‘ghost-like’ feature which marked the beginning of adipogenesis. Morphology of ASC after 21 days’ adipogenic induction at P5 (B) and P20 (D). Oil Red O staining of differentiated ASC at P5 (C) and P20 (E). Differentiated ASC at P10 and P15 have similar features as ASC at P5. Magnification 200×
Adipogenic gene expression in extensive culture of adipose-derived stem cells
The PPAR (Figure 4A) increased in expression after adipogenic induction at all passages. At P5, the PPAR expression level after induction increased to 5.31E-03 ±1.94E-03 compared to before induction. At P10, the PPAR expression level increased significantly (p < 0.05) to 6.62E-03 ±2.90E-03 compared to before induction. The expression also increased significantly at P15 and P20 (p < 0.05) from 7.05E-04 ±3.11E-04 to 9.58E-03 ±4.74E-03 and from 1.46E-03 ±3.22E-04 to 3.75E-03 ±1.08E-03, respectively, after induction. Among the entire induced group, PPAR expression level was significantly the highest at P15 (p < 0.05) compared to P5 and P10.
Figure 4
Relative changes in adipogenic gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – PPAR gene; B – LPL gene and C – aP2 gene expression level
*p < 0.05 relative to before induction by paired t-test, ▲p < 0.05 relative to P5 after induction by one-way ANOVA post hoc Tukey, ●p < 0.05 relative to P10 after induction by one-way ANOVA post hoc Tukey
Relative changes in adipogenic gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – PPAR gene; B – LPL gene and C – aP2 gene expression level*p < 0.05 relative to before induction by paired t-test, ▲p < 0.05 relative to P5 after induction by one-way ANOVA post hoc Tukey, ●p < 0.05 relative to P10 after induction by one-way ANOVA post hoc TukeyThe LPL (Figure 4B) increased in expression after ASC induced in adipogenic medium at all passages. At P5, LPL increased from 2.60E-06 ±1.54E-06 to 3.56E-04 ±7.55E-04, while at P10, LPL increased in expression from 3.18E-06 ±2.49E-06 to 1.62E-03 ±1.51E-03. At P15 it increased significantly from 5.58E-07 ±3.23E-07 to 1.70E-03 ±1.59E-03. At P20 there was only a slight increase in expression of LPL from 3.89E-07 ±2.25E-07 to 4.89E-06 ±3.61E-06. Among the entire induced group, P15 showed the highest expression level of LPL compared to other passages. It is statistically significant when compared to P10 (p < 0.05). In contrast, at P20, the expression level of LPL is the lowest and it is statistically significant (p < 0.05) when compared to P5 and P10.aP2 (Figure 4C) also increased in expression after adipogenic induction although not as high as PPAR and LPL. At P5 and P10, it increased significantly (p < 0.05) from 1.37E-05 ±5.12E-06 to 1.66E03 ±1.90E-03 and from 7.19E-06 ±2.16E-06 to 1.31E-03 ±1.07E-03 respectively. At P15, there was slight increase in aP2 expression from 8.07E-06 ±3.99E-06 to 1.28E-05 ±5.95E-06, while at P20, the aP2 expression level increased significantly (p < 0.05) from 5.81E-06 ±3.49E-06 to 1.04E-04 ±7.13E-05. Among all the induced groups, aP2 expression was the highest at P5 and the lowest at P15 compared to other passages. The aP2 expression at P15 was significantly decreased (p < 0.05) compared to P5 and P10. While at P20, aP2 was also significantly decreased (p < 0.05) compared to P5 and P10.
Osteogenic gene expression in adipose-derived stem cells after adipogenesis
Apart from adipogenic genes, osteogenic genes, i.e. ALP, OSP, BSP, OSC and RUNX, were also evaluated under adipogenic differentiation. There were no significant changes in the osteogenic gene expression levels during adipogenic induction with the exception of OSP. These genes showed low expression levels during adipogenic induction with no significant difference compared to before induction. The ALP showed a modest increase in expression at P10, P15 and P20 compared to before induction (Figure 5A), while OSP (Figure 5B) showed a modest increase in expression at P5, P10 and P15 but there was a significant increase at P20 (p < 0.05) compared to before induction, from 4.47E-04 ±1.44E-04 to 2.66E04 ±1.04E-04. The OSC (Figure 5C) showed a very low expression at all passages compared to before induction. RUNX (Figure 5D) and BSP (Figure 5E) showed a modest increase at P15 and P20 after induction.
Figure 5
Relative changes in osteogenic gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – ALP gene, B – OSP gene, C – OSC gene, D – RUNX gene and E – BSP gene expression level
*p < 0.05 relative to before induction by paired t-test
Relative changes in osteogenic gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – ALP gene, B – OSP gene, C – OSC gene, D – RUNX gene and E – BSP gene expression level*p < 0.05 relative to before induction by paired t-test
Stemness gene expression in adipose-derived stem cells after adipogenesis
Stemness gene expression was also studied before and after adipogenic induction at P5, P10, P15 and P20. Nanog3 (Figure 6A) showed a significant increase (p < 0.05) in expression levels after adipogenic induction at P15 (before: 3.71E-05 ±7.05E-06; after: 5.70E-05 ±1.61E-05) and P20 (before: 4.93E-05 ±8.09E-06; after: 1.05E-04 ±2.91E-05). Sox2 (Figure 6B), Nestin (Figure 6C) and Oct4 (Figure 6E) showed no significant changes in expression levels at all the passages. However, BST1 (Figure 6D) showed a significant decrease (p < 0.05) in expression at P5 (before: 2.64E-02 ±8.27E-03; after: 7.03E-03 ±1.73E-03), P10 (before: 2.54E-02 ±7.82E-03; after: 1.53E-03 ±2.64E-04), P15 (before: 1.86E-02 ±1.73E-03; after: 1.60E-03 ±5.12E-04) and P20 (before: 1.81E-02 ±7.13E-03; after: 1.01E-02 ±1.09E-03) after adipogenic induction.
Figure 6
Relative changes in stemness gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – Nanog gene, B – Sox2 gene, C – Nestin gene, D – BST1 gene and E – Oct4 gene expression level
*p < 0.05 relative to before induction by paired t-test
Relative changes in stemness gene expression levels in ASC at P5, P10, P15 and P20 before and after adipogenic induction (n = 6). A – Nanog gene, B – Sox2 gene, C – Nestin gene, D – BST1 gene and E – Oct4 gene expression level*p < 0.05 relative to before induction by paired t-test
Discussion
Adipogenic cells can be easily distinguished by alteration in cell shape where the fibroblastic cells changes to spherical shape cells after induction [9]. From the evaluation of morphology and adipogenic gene expression levels, the ASC were found to be able to differentiate into adipogenic cells up to P20. We did not study passages beyond P20 since the cells became protracted and unable to reach the seeding density that was needed for adipogenic differentiation. In addition, some cells at P20 have already shown senescence characteristics and inability to withstand the toxicity of the adipogenic medium. Some of these cells died before the formation of lipid droplets could occur.At passages 5, 10 and 15, PPAR-γ and LPL expression levels increased significantly, while aP2 expression levels only increased up to P10 and to a lesser extent at P15 and P20. This showed that ASC were able to differentiate into mature adipogenic cells up to P10 and to a lesser extent at P15. This was also supported by the decline in the formation of oil droplets at later passages. In addition, aP2 was the first to decline (starting from P10) in expression in extensive culture. The aP2 gene plays an important role in the development of metabolic syndrome and the coordination of cholesterol trafficking as well as inflammatory activity [13, 14]. This indicates that in extensive culture, ASC may lose their adipogenic differentiation ability starting from P10. Izadpanah et al. also reported that ASCs significantly lost adipogenic potential but this occurred after P20 [21]. However, Wall et al. reported a similar result that ASCs were only capable of undergoing adipogenesis up to P10 [16]. In this study, we found that cells after P10 lose their ability to differentiate into adipogenic cells, which is in contrast to Izadpanah et al. In addition, the aP2 gene may be used as an indicator for adipogenic differentiation efficiency.We also found that osteogenic genes, i.e. ALP, OSC, OSP, BMP and RUNX, were expressed during adipogenic induction but the expression levels were low and there was no significant change in their expression level after induction with the exception of OSP, which showed a significant increase at P20 after induction. While it is tempting to claim that there is a possibility of osteogenic dominance during adipogenic differentiation at later passage as reported by Wall et al. [16], the increase of OSP expression at P20 alone is not enough to justify that notion. Furthermore, there was no calcium deposition observed in our morphological study as reported by Wall et al. [16]. On the other hand, certain osteogenic genes may not be exclusively involved in the development of osteoblasts but could also play a role in the development of other cell types, e.g. the ALP gene, which was reported to be involved in intracellular lipid accumulation in 3T3-L1 cells and human preadipocytes [22]. In addition, adipogenic and osteogenic differentiation were suggested as parallel events [23] and not inverse events as found in another study [24]. However, data from our quantitative PCR analysis did not indicate that adipogenic and osteogenic differentiation are parallel events.Most of the stemness genes with the exception of Nanog3 showed either a decrease or no significant changes in expression levels after adipogenic induction, which showed that the ASC may have terminally differentiated into specific cells, in this case adipocytes, thus reducing the number of stem cells in the whole cell population. Nanog3 showed an increase in expression at all passages after adipogenic induction with a significant increase at P15 and P20. However, when compared among passages, the expression of Nanog3 after adipogenic induction decreased at P15 and P20 compared to P5 and P10. Nanog supports stem cell self-renewal as well as maintenance of ESC pluripotency [25, 26]. It interacts with Oct4 and Sox2 to induce self-renewal and differentiation [27]. However, increase or over-expression of Nanog has been found to slow down the progression of adipogenesis [28]. This suggests that increase in Nanog3 expression may also contribute to the decrease in the differentiation ability of ASC into mature adipocytes, especially at later passages in the current study. Nanog3 can become an indicator to evaluate the capacity of stem cells to differentiate into adipogenic cells.In conclusion, the ASCs’ ability to differentiate into mature adipogenic cells started to decrease in culture higher than P10 according to quantitative PCR and morphological analysis. Therefore, ASC culture at later passages (P15 and P20) is not suitable for adipogenic differentiation. The expression of stemness genes showed that the stem cell pool in the whole cell population decreased due to cell differentiation. The data on osteogenic gene expression suggested that the processes of osteogenesis and adipogenesis were not parallel events.
Authors: Aus T Ali; Clem B Penny; Janice E Paiker; George Psaras; Faisel Ikram; Nigel J Crowther Journal: Anal Biochem Date: 2006-05-11 Impact factor: 3.365
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli Journal: Pharmacol Rev Date: 2006-12 Impact factor: 25.468
Authors: M L Ponce; S Koelling; A Kluever; D E H Heinemann; N Miosge; G Wulf; K-H Frosch; N Schütze; M Hufner; H Siggelkow Journal: J Cell Biochem Date: 2008-07-01 Impact factor: 4.429
Authors: Anoosha Forghani; Lisa Kriegh; Katie Hogan; Cong Chen; Gabrielle Brewer; Timothy B Tighe; Ram Devireddy; Daniel Hayes Journal: J Biomed Mater Res A Date: 2017-02-24 Impact factor: 4.396